BioSpace News Archive

Centene Corporation (NYSE: CNC) (" Centene " or the " Company ") announced today that it has commenced a cash tender offer (the " Tender Offer ") for any and all of its outstanding 4.75% Senior Notes due 2025 (the " 2025 Notes "). The Tender Offer is being made on the terms and subject to the conditions set forth in the Offer to Purcha

Doximity, the largest U.S. professional medical network, today announced the appointment of Tim Cabral to its board of directors and chair of the company’s audit committee.

LipoMedix, a clinical-stage, oncology-focused pharmaceutical company involved in the development of innovative, safe and effective cancer therapy based on a pegylated liposomal drug delivery platform, today announced that its lead compound, Promitil® (PL-MLP)

Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the BTIG MedTech and Digital Health Conference on Thursday, February 18, 2021 at 11:00 a.m. Eastern Time.

OCALA, Fla., Feb. 10, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that the Dutch Health and Youth Care Inspectorate (IGJ) has approved treatment for six pancreatic cancer patients as part of a new, follow-up Early Access Program (EAP) at Erasmus Medical Center in the Netherlands. Subject to further authorization we plan to treat up to 16 pancreatic cancer patients with rintatolimod (Ampligen) under the EAP, which follows the success of a previous multi-yea

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today acquisition of the JadiCell™, cell therapy, for use in the treatment of acute respiratory distress syndrome and other lung pathologies

Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO), announced today that Phillip Doyle will join as Global Head of Quality.

Galapagos NV (Euronext & Nasdaq: GLPG) and Gilead Sciences (Nasdaq: GILD) today announced the decision to halt the ISABELA Phase 3 clinical studies with the investigational autotaxin inhibitor ziritaxestat in patients with idiopathic pulmonary fibrosis.

Arctoris Ltd, an Oxford-based technology company operating a fully automated drug discovery platform, celebrated its 5th anniversary on the 4th of February.

Elite Pharmaceuticals, Inc. (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that it will release its 2021 third-quarter financial results on Tuesday, February 16, 2021.